Matthew Budoff, David Geffen School of Medicine at UCLA, Los Angeles, USA, discusses imaging data supporting the benefits of eicosapentaenoic acid on plaque regression, compared with the effects of fibrates and PCSK9 inhibitors.
Please login or create a FREE account to view this content
Educational Supporters of the 11th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:
Guest supporters:
